XU ZHENYU (Chief Scientific Officer) sold 3.4% of their position (20K shares) of SOPHIA GENETICS SA on the open market
Open‑market sale worth $163.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/21/2026ACC: 0001840706-26-000292
Officer· Chief Scientific Officer
Since Mar 2026
-20K
Net shares
Net seller
$163.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
20K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−10K
Price / share
$7.94
Trade value
$79.43K
% of position
1.7%
8/19/2026
586.89K→576.89K
Ordinary Shares
Direct
Shares
−4.59K
Price / share
$8.41
Trade value
$38.61K
% of position
0.8%
8/20/2026
576.89K→572.29K
Ordinary Shares
Direct
Shares
−5.41K
Price / share
$8.40
Trade value
$45.45K
% of position
0.9%
8/21/2026
572.29K→566.89K
Total
Net shares
−20K
Net value
-$163.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/19/2026 | S · Sale | −10K | $7.94 | $79.43K | 1.7% | 586.89K | 576.89K |
| Ordinary Shares Direct | 8/20/2026 | S · Sale | −4.59K | $8.41 | $38.61K | 0.8% | 576.89K | 572.29K |
| Ordinary Shares Direct | 8/21/2026 | S · Sale | −5.41K | $8.40 | $45.45K | 0.9% | 572.29K | 566.89K |
| Total | −20K | -$163.48K | ||||||
Derivative Transactions0
No derivative transactions reported